Kim Kardashian showed up in an FDA warning letter when the agency's Office of Prescription Drug Promotion (OPDP) cited Duchesnay Inc., of Rosemont, Pa., for Kardashian's social media post promoting its morning sickness drug Diclegis (doxylamine succinate and pyridoxine hydrochloride) delayed-release tablets.